Clinical Trial Update: Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating cyclophosphamide plus cyclosporine in treatment-naive severe aplastic anemia; the study status is completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Cytoxan (cyclophosphamide)
• NEORAL (CYCLOSPORINE)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Aplastic Anemia, Neutropenia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-11-11